All data are based on the daily closing price as of December 24, 2024
s
SD BioSensor
137310.KO
7.20 USD
-0.13
-1.77%
Overview
Last close
7.20 usd
Market cap
881.23M usd
52 week high
11.72 usd
52 week low
5.63 usd
Target price
7.54 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.9647
Price/Book Value
0.4479
Enterprise Value
880.54M usd
EV/Revenue
1.9062
EV/EBITDA
225.9278
Key financials
Revenue TTM
448.53M usd
Gross Profit TTM
1.03B usd
EBITDA TTM
33.36M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
3,801.72B usd
Net debt
263.26B usd
About
SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company's products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters. The company was founded in 2010 and is headquartered in Suwon, South Korea.